4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000158
Director sold 7,073 shares at $448.00 ($3,168,704)
- Director acquired 7,073 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SACHS BRUCE I · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,073 | $93.51 | $661,396 | 47,073 | D |
| 2024-05-22 | Sale : show line 2 in the form 10b5-1 | −7,073 | $448.00 | $3,168,704 | 40,000 | D |
| Open-market sales · 7,073 sh · avg $448.00 · $3,168,704 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-05-22 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −7,073 | $93.51 | 2026-05-31 | 7,073 | 0 | D |
Loading xslF345X05/wk-form4_1716581569.xml…